Neurophysiology Flashcards
autonomic nervous system
= set of pathways to and from the CNS that innervate and regulate
- smooth muscle
- cardiac muscle
- glands
three divisions of the ANS
- sympathetic
- parasympathetic
- enteric nervous systems
parasympathetic NS features
- origin of preganglionic nerve
- preganglionic axon length
- nt to autonomic ganglia
- receptor type at ganglia
- postganglionic axon length
- nt to effector organ
- receptor type at effector organ
- origin of preganglionic nerve = CN 3, 7, 9, 10; spinal segments S2-S4 (craniosacral)
- preganglionic axon length: long
- nt to postganglionic: Acetylcholine (ACh)
- receptor type at ganglia: nicotinic
- postganglionic axon length: short
- nt to effector organ: ACh
- receptor type at effector organ: muscarinic
sympathetic NS features
- origin of preganglionic nerve
- preganglionic axon length
- nt to autonomic ganglia
- receptor type at ganglia
- postganglionic axon length
- nt to effector organ
- receptor type at effector organ
- origin of preganglionic nerve = T1-12, L1-3 (thoracolumbar)
- preganglionic axon length: short (terminates in the paravertebral chain of ganglia)
- nt to postganglionic: ACh
- receptor type at ganglia: nicotinic
- postganglionic axon length: long
- nt to effector organ: norepinephrine (except sweat glands, which use ACh)
- receptor type at effector organ: alpha-1, alpha-2, beta-1, beta-2
effector organs of the somatic nervous system
skeletal muscle
neurotransmitter of the somatic NS
ACh
receptor type of the somatic NS
nicotinic
adrenal medulla and special anatomy
= specialized ganglion of the sympathetic nervous system; pregangllionic fibers synapse directly on chromaffin cells in the adrenal medulla–> secretion of epinephrine (80%) and norepinephrine (20%)
pheochromocytoma
= tumor of the adrenal medulla that secrete excessive amts of catecholamines and is associated with increased excretion of 3-methyoxy-4-hydroxymandelic acid (VMA)
adrenergic nerve fiber
= a neuron for which the neurotransmitter is either epinephrine, norepinephrine, or dopamine; usually norepinephrine
cholinergic neuron
= a neuron for which the neurotransmitter is acetylcholine (ACh); present in both the sympathetic and parasympathetic NSs
receptors types of the ANS
- adrenergic (nt = norepinephrine)
2. cholinergic (nt = ACh)
special parasympathetic receptors of the GIT
= nonadrenergic, noncholinergic receptors of some postganglionic parasympathetic neurons in the GIT, which release
- substance P
- vasoactive intestinal peptide (VIP)
- nitric oxide (NO)
types of adrenergic receptors
- alpha-1
- alpha-2
- beta-1
- beta-2
two broad categories of cholinergic receptors (cholinoreceptors) and specific types of cholinergic receptors
categories of cholinergic receptors
- nicotinic receptors
- muscarinic receptors
specific types of cholinergic receptors
- Nm (N1)
- Nn (N2)
- M1
- M2
- M3
alpha-1 receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location = 1. smooth muscle (vascular smooth muscle of the skin and splanchnic regions, GIT, and bladder sphincters), 2. radial muscle of the iris
- result of activation = excitation (contraction/constriction)
- nt sensitivity = equally responsive to norepi and epi but ONLY norepi released from adrenergic neurons is present in high enough concentrations to activate alpha-1 receptors
- G protein = Gq
- mechanism = Gq–> stimulation of phospholipase C–> increase IP3 and intracellular Ca2+
alpha-2 receptors
- location
- result of activation
- nt sensitivity*
- G protein
- mechanism
- location: 1. walls of GIT (heteroreceptors), 2. sympathetic postganglionic nerve terminals (autoreceptors), platelets, fat cells
- result of activation: inhibition (relaxation/dilation)
- nt sensitivity*
- G protein: Gi
- mechanism: Gi–>inhibition of adenylate cyclase–> decrease in cAMP
beta-1 receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: Heart (1. SA node, 2. AV node, 3. ventricular muscle)
- result of activation: excitation (increase HR, increase contraction velocity, increase contractility)
- nt sensitivity: equally sensitive to norepi and epi; more sensitive than alpha-1 receptors
- G protein: Gs
- mechanism: Gs–>activate adenylate cyclase–>increase cAMP
beta-2 receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: smooth muscle (1. bronchial smooth muscle, 2. vascular smooth muscle of skeletal muscle, 3. walls of GIT and bladder)
- result of activation: relaxation (dilation of bronchioles, dilation of vascular smooth muscle, relaxation of the bladder wall)
- nt sensitivity: more sensitive to epi than norepi (epi>norepi); more sensitive to epi than alpha-1 receptors
- G protein: Gs
- mechanism: Gs–>activate adenylate cyclase–>increase cAMP
Nm (N1) nicotinic cholinergic receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: skeletal muscle neuromuscular junction (somatic nervous system)
- result of activation: excitation
- nt: ACh or nicotine
- G protein: n/a
- mechanism: opening Na/K channels (because nicotinic ACh receptors are also ion channels for Na and K)
Nn (N2) nicotinic cholinergic receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: autonomic ganglia (of both the sympathetic and parasympathetic NS); adrenal medulla
- result of activation: excitation
- n: ACh or nicotine
- G protein: n/a
- mechanism: opening Na/K channels
M1 muscarinic cholinergic receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: CNS
- result of activation
- nt: ACh or muscarine
- G protein: Gq
- mechanism: Gq–>increase phospholipase C activity–>increase IP3/Ca
M2 muscarinic cholinergic receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: heart
- result of activation: inhibition (decreased HR, decreased conduction velocity of the AV node)
- nt: ACh or muscarine
- G protein: Gi
- mechanism: Gi–>inhibit adenylate cyclase–>decrease cAMP–>opening of K channels–>slowing of the rate of spontaneous phase 4 depolarization–>decreased heart rate
M3 muscarinic cholinergic receptors
- location
- result of activation
- nt sensitivity
- G protein
- mechanism
- location: glands, smooth muscle
- result of activation: excitatory (increased GI motility, increased secretion)
- nt: ACh or muscarine
- G protein: Gq
- mechanism: Gq–>increase phospholipase C activity–>increase IP3/Ca